TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

Clinical trial NCT00203359 · COMPLETED

Trial details

NCT number: NCT00203359
Sponsor: Tobinick, Edward Lewis, M.D.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2004-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.